TITLE

Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats

AUTHOR(S)
Velin, A K; Ericson, A-C; Braaf, Y; Wallon, C; Söclerholm, J D
PUB. DATE
April 2004
SOURCE
Gut;Apr2004, Vol. 53 Issue 4, p494
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Chronic stress affects the course of inflammatory bowel disease and experimental colitis, and may also initiate intestinal inflammation in rats. Aim: To investigate the effects of stress on the M cell containing follicle associated epithelium, specialized in antigen uptake. Subjects and methods: Wistar rats were submitted to acute water avoidance stress for one hour or chronic water avoidance stress for 1 hour/day for 10 consecutive days. Permeability to 51Cr-EDTA, horseradish peroxidase, and chemically killed Escherichia coli K- 12 was studied in both villus and follicle associated epithelium in Ussing chambers. Segments were further examined by light, electron, and confocal microscopy. Results: Acute stress increased horseradish peroxidase flux in villus as well as in follicle associated epithelium. Chronic stress further increased permeability to horseradish peroxidase in villus and follicle e associated epithelium, in the latter by almost fourfold. Moreover, chronic stress induced over 30 times increased E coli passage in follicle associated epithelium whereas there was no significant increase in villus epithelium. Bacterial uptake was confirmed by confocal microscopy showing fluorescent bacteria penetrating and passing through the epithelial surface. Conclusions: These results show that the barrier function of follicle associated epithelium can be modulated, and that chronic stress enhances the uptake of luminal antigens and bacteria via the follicle associated epithelium. This can increase antigen exposure in Peyer's patches thereby having implications in the initiation of proinflammatory immune responses within the intestinal mucosa.
ACCESSION #
13120613

 

Related Articles

  • Probiotic is useful for ulcerative colitis. Kruis, W.; Fric, P.; Pokrotnieks, J. // BMJ: British Medical Journal (International Edition);5/7/2005, Vol. 330 Issue 7499, Preceding p1035 

    Looks at the use of the probiotic Escherichia coli Nissle 1917 (EcN) in the treatment of ulcerative colitis. View that EcN is a Gram negative probiotic and may work by causing an immune response or preventing invasion of other bacteria; Review of study investigating the effect of EcN on...

  • AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Chassaing, Benoit; Koren, Omry; Carvalho, Frederic A.; Ley, Ruth E.; Gewirtz, Andrew T. // Gut;Jul2014, Vol. 63 Issue 7, p1069 

    Background Inflammatory bowel disease (IBD) is driven by a seemingly aberrant immune response to the gut microbiota with disease development dictated by genetics and environmental factors. A model exemplifying this notion is our recent demonstration that colonisation of adherent-invasive...

  • Recent Approaches in Pathogenesis of Inflammatory Bowel Disease. Solanki, Roshni; Madat, Dhaval; Chauhan, Khushbu; Parmar, Lalkrushn // International Journal of PharmTech Research;Jul-Sep2010, Vol. 2 Issue 3, p1796 

    Inflammatory bowel disease (IBD) commonly refers to ulcerative colitis (UC) and Crohn disease (CD), which are chronic inflammatory diseases of the GI tract of unknown etiology. This inflammatory response is most likely made possible by defects in both the mucosal immune system and the barrier...

  • "Germ Warfare" for Ulcerative Colitis? Bahrani, Otarod; Flemmer, Mark // American Journal of Gastroenterology;Apr2001, Vol. 96 Issue 4, p1293 

    A single center randomized double dummy study was undertaken in 116 patients; 59 were randomized to mesalamine and 57 to receive a nonpathogenic strain of Escherichia coli. In addition, all patients received standard medical therapy, together with a 1-wk course of oral gentamicin. After...

  • The Hair of the Dog. Bahrani, Otarod; Flemmer, Mark; Johnson, David // American Journal of Gastroenterology;Sep2001, Vol. 96 Issue 9, p2789 

    A single-center randomized double dummy study was undertaken in 116 patients; 59 were randomized to mesalamine and 57 to receive a nonpathogenic strain of Escherichia coli. In addition, all patients received standard medical therapy, together with a 1-wk course of oral gentamicin. After...

  • Escherichia coli and ulcerative colitis. Burke, Denis // Journal of the Royal Society of Medicine;Nov1997, Vol. 90 Issue 11, p612 

    The article provides information about ulcerative colitis and escherichia coli. The clinical characteristics of acute ulcerative colitis in relapse are quite similar to that of infectious colitis. Conflicting results have been produced by the quantitative studies of the faecal flora in...

  • Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). Matthes, Harald; Krummenerl, Thomas; Giensch, Manfred; Wolff, Corinna; Schulze, Jürgen // BMC Complementary & Alternative Medicine;2010, Vol. 10, p13 

    Background: Probiotics are effective in inflammatory bowel diseases. Clinical effectiveness and dose dependency of E. coli Nissle (EcN) enemas were investigated in ulcerative colitis (UC). Methods: In a double-blind study, 90 patients with moderate distal activity in UC were randomly assigned to...

  • The forgotten role of lymphangitis in Crohn's disease. Kruiningen, H J Van; Colombel, Jean-Frédéric // Gut;Jan2008, Vol. 57 Issue 1, p1 

    Research into Crohn's disease has recently been focused on the genetics of the patient, the gastrointestinal flora, the gut epithelium and mucosal immune responses. For over 60 years pathologists have reported that the fundamental alteration in Crohn's disease occurs in regional lymphatics of...

  • Role of STAT3 in inflammatory bowel disease. Sugimoto, Ken; Mizoguchi, Atsushi; Hoentjen, Frank; McCormick, Beth A.; Bauer, Anthony J. // World Journal of Gastroenterology;9/7/2008, Vol. 14 Issue 33, p5110 

    Signal transducers and activators of transcription 3 (STAT3) play an important role in various autoimmune disorders including inflammatory bowel disease (IBD). Recent studies have revealed that STAT3 activation plays distinctly different roles between innate immune responses and acquired immune...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics